← Open Payments lookup

LEA SHERMAN: Open Payments

NPI 1235771932 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,655 in 87 payments from 10 companies in 2025. Trend: 2023 $520 · 2024 $865 · 2025 $1,655

Food & beverage: $1,543Education: $111
CompanyPaymentsAmount
Alkermes, Inc.23$334
Teva Pharmaceuticals USA, Inc.14$313
Otsuka America Pharmaceutical, Inc.13$262
Janssen Pharmaceuticals, Inc10$193
Neurocrine BioSciences, Inc.6$171
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$155
E.R. Squibb & Sons, L.L.C.6$98
ABBVIE INC.3$63
Lundbeck LLC2$48
Vanda Pharmaceuticals Inc.1$17

Products named: ARISTADA, REXULTI, INVEGA SUSTENNA, INGREZZA, CAPLYTA, AUSTEDO XR, COBENFY, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.